Patent · US Active

Ligand discovery and gene delivery via retroviral surface display

US12222347B2 · kind B2 · utility

1Cited by
2References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 30, 2023
Grant dateFeb 11, 2025
Priority date
Expiry dateAug 30, 2043

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/5047
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Compositions of retroviruses and methods of using the same for gene delivery are disclosed, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.